Novartis Consumer Health Recall: Excedrin Migraine (Acetaminophen 250 mg, Aspirin (NSAID)
Novartis Consumer Health Recall: Excedrin Migraine (Acetaminophen 250 mg, Aspirin (NSAID) is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Novartis Consumer Health; Product: Excedrin Migraine (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-count tablets packaged
| Recalling firm | Novartis Consumer Health |
|---|---|
| Product | Excedrin Migraine (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-count tablets packaged in pouches, Distributed by Novartis Consumer Health, Inc., Parsippany, NJ, NDC 0067 203 702 Foreign packaging: b) Excedrin Migrana (Acetaminophen 250 mg, Aspirin 250 mg and 65 mg Caffeine) 2-ct pouches. The foreign packaging do not have NDC numbers |
| Reason for recall | Defective container: products are packaged in pouches which may not have been fully sealed |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide, Puerto Rico, Brazil and Panama |
| Recall initiated | 20130606 |
| Recall number | D-844-2013 |
| Category | drug |
| State | NE |
| Country | United States |
$29/mo
Try RecallGuard →